Skip to content
Tirzepatide Report
Provider review

No BS RX Tirzepatide Review: Prices, Renewal & Refunds

Published by Tirzepatide ReportUpdated

On this page

Standard compounded tirzepatide $225 monthly, with separate $115 low-dose and $1,299 branded Zepbound programs.

Standout details

  • Publishes standard, low-dose and branded prices separately
  • Specific GLP-1 policy includes clinical and pharmacy costs

Things to consider

  • Week-based prepaid blocks differ from monthly billing
  • Cancellation requires support confirmation by email

No BS RX lists its standard compounded tirzepatide injection at $225 monthly, with separate prepaid blocks. A low-dose compounded injection is $115 monthly, while a distinct branded Zepbound program is $1,299 monthly. These are different treatment options, not equivalent doses or preparations.5

Compare the program and its supplied period

DecisionPublished condition
Standard monthly$225
Standard prepaid blocks$548 / 12 weeks; $1,142 / 24 weeks; $2,225 / 52 weeks
Low-dose compounded$115 monthly or $340 / 12 weeks
Branded Zepbound$1,299 monthly; distinct product
Standard block prices describe week-based terms; the low-dose and branded options are separate.

The pricing and October subscription policy include consultation, medication, shipping and provider messaging for GLP-1 programs, with no separate provider or pharmacy charge. The specific GLP-1 inclusion clause qualifies the same policy's generic discussion of separately billed third-party services. Confirm your selected program rather than treating that generic paragraph as a mandatory extra fee.5,6

The current Rx.com, Edessa and RX Bella reviews help compare term totals and inclusions. Longer blocks are stated in weeks and should not be silently converted into calendar-month billing.5

Who prescribes and dispenses

No BS RX describes itself as an administrative and technology platform; independent clinicians decide treatment. Its Terms list Red Rock, Health Warehouse, Precision Medicine and Triad Rx as possible dispensing pharmacies. The pricing page attributes compounded fulfillment to 503A pharmacies. Neither statement independently verifies an assigned facility's current license or the quality of a prescription.5,8

The Science & Co review provides another platform model to compare. Eligibility, preparation and availability remain clinician- and state-dependent; a paid intake does not guarantee a prescription.8

Email cancellation before renewal

Subscriptions renew for successive periods of the same duration. Cancellation is handled by support email, with confirmation by email, rather than a self-service portal switch. Send the request before renewal; the inspected subscription policy does not set a numerical 48- or 72-hour cutoff. Access continues to the paid-period end, and cancellation does not itself refund that period.6

DecisionPublished condition
Future renewalEmail before renewal; support confirms cancellation
Initial clinician denialFull platform, consultation and medication payment refunded
Other initial cancellationWithin 48 hours only before intake/review begins
Later discontinuation or dispensed medicineNo equivalent blanket refund promise
Initial ineligibility has a specific full-payment refund exception.

The refund policy expressly refunds the full initial payment, including platform, consultation and medication amounts, when the initial clinician review finds the patient ineligible. That exception overrides its general completed-consultation nonrefund rule. A later treatment adjustment or discontinuation does not create the same right. Apart from initial denial, a 48-hour initial-payment refund requires that no intake or clinical review has begun; dispensed medication and completed billing periods are generally nonrefundable.7

Compounded versus branded treatment

The separately offered Zepbound program is not the compounded injection or the low-dose program. The Zepbound sleep-apnea guide discusses the branded drug's clinical use; it does not establish an indication or equivalent results for a compounded preparation. Our compounded tirzepatide legal-status guide explains the regulatory distinction.

Does the drug work? (Separate from the provider)

SURMOUNT-1 put weight loss at roughly 15% to 21% of body weight over 72 weeks3, and SURMOUNT-5 placed it ahead of semaglutide head to head4, both on the approved brand product. Our tirzepatide evidence guide has the full picture.

Before choosing a longer plan

Confirm the medication, supplied quantity, shipment schedule and renewal date. The current Renlo Health review offers another payment and refund structure; our provider comparison brings together the broader field.

Frequently asked questions

Is $115 the standard tirzepatide plan?

No. It is the low-dose compounded injection program. The standard compounded injection is $225 monthly, and branded Zepbound is a separate $1,299 monthly program. A clinician determines appropriate treatment.5

Are care and medication billed separately?

The October subscription policy specifically says GLP-1 program prices include consultation, medication, shipping and messaging without separate provider, pharmacy or shipping fees. Other programs can have different fees.6

How do I stop automatic renewal?

Email support before the renewal date and obtain its confirmation. Cancellation is not a self-service portal action; it ends future renewal rather than refunding the current paid period.6

What if the clinician declines treatment?

Initial ineligibility triggers a full refund including platform, consultation and medication amounts. That does not extend to every later treatment change or to already dispensed medication.7

References(8)

  1. No BS RX (2026). GLP-1 program pricing table — six programs across monthly, 12-week, 24-week and 52-week terms, with the sleep program and the stated pricing commitments. nobsrx.com.
  2. No BS RX (2026). Terms of Service — the four independent, state-licensed dispensing pharmacies, with addresses and telephone numbers. nobsrx.com.
  3. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  4. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  5. No BS RX (2026). Pricing: standard, low-dose and brand-name programs (accessed October 26, 2026). Official provider public page.
  6. No BS RX (2026). Subscription Terms, updated October 2026 (accessed October 26, 2026). Official provider public page.
  7. No BS RX (2026). Refund Policy, updated October 2026 (accessed October 26, 2026). Official provider public page.
  8. No BS RX (2026). Terms of Service, updated August 2026 (accessed October 26, 2026). Official provider public page.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.